Neogen (NEOG) Stock Price & Analysis
NEOG Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- MXN 48.48B
- Enterprise Value
- MXN 3.12B
- Total Cash (Recent Filing)
- MXN 172.00M
- Total Debt (Recent Filing)
- MXN 774.20M
- Price to Earnings (P/E)
- ―
- Beta
- N/A
- Next Earnings
- Jan 14, 2027 (Est.)
- EPS Estimate
- 1.16
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Recurring Consumables Model
Neogen benefits from repeat testing tied to regulatory standards and customer quality programs. Consumable replenishment can create recurring revenue, while instruments and workflow products support cross-selling and deepen customer relationships over time.
Raised Operating Outlook
Higher fiscal-year guidance indicates management sees sufficient commercial traction to support stronger revenue and EBITDA expectations. Planned efficiency programs may also expand margins, improving operating leverage and execution capacity over the next several quarters.
Improving Cash Generation
Positive operating and free cash flow provide internal funding for innovation, technology and operational improvements. The recent cash-generation recovery strengthens financial flexibility, even though sustained conversion will depend on maintaining execution and avoiding renewed volatility.
Bears Say
Persistent Unprofitability
Ongoing net losses and negative EBIT show that revenue has not yet translated into consistent GAAP profitability. This weakens earnings quality, limits internally generated capital, and leaves results more exposed to execution issues or cost increases over the medium term.
Petrifilm Transition Execution Risk
The multi-quarter Petrifilm manufacturing transfer creates a temporary but meaningful execution burden. Duplicative costs and the need to manage customer continuity, suppliers and inventory could pressure margins and working capital before the expected longer-term benefits arrive.
End-market Pressure
Pressure on food and animal safety customers can constrain purchasing activity and delay testing-related decisions. Low U.S. herd levels may also weigh on animal-safety demand, making near-term growth more dependent on international expansion and execution.
Neogen News
NEOG FAQ
What is Neogen’s market cap?
When is Neogen’s upcoming earnings report date?
How were Neogen’s earnings last quarter?
Is Neogen overvalued?
Does Neogen pay dividends?
What is Neogen’s EPS estimate?
How many shares outstanding does Neogen have?
What happened to Neogen’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Neogen?
What is the TipRanks Smart Score and how is it calculated?
Neogen Stock Smart Score
Company Description
Neogen
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mikhael Nassif
- Employees
- 2,636
- Website
- www.neogen.com
- Address
- 620 Lesher Place, Lansing, MI, 48912-1595, US
Neogen (NEOG) Earnings & Revenues
NEOG Company Deck
NEOG Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Neogen reported broad-based revenue growth, improved adjusted EBITDA margins and free cash flow, raised fiscal 2027 guidance, advanced commercial and innovation initiatives, and reached an important Petrifilm validation milestone. Management also highlighted near-term growth timing effects, macroeconomic pressures, transition-related duplicative costs and a full-year EBITDA margin outlook roughly similar to fiscal 2026, but described these issues as understood and incorporated into its plans.
View all MX:NEOG earnings summaries